A Multi-national, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab Actemra
Phase of Trial: Phase IV
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 19 May 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Apr 2014 to 1 Mar 2014.
- 19 May 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 07 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.